HPV Testing and PAP Test Market Analysis

HPV Testing and PAP Test Market Analysis

To get key market trends

  Download Free Sample

With respect to test type, the HPV testing market size is projected be worth USD 4.8 billion by 2032. The growth can be attributed to the increasing awareness regarding cervical cancer and the growing number of sexually active people. The rapidly expanding homosexual population along with the increasing number of individuals affected with weakened immune systems has stirred the higher risk of contracting HPV, subsequently amplifying the awareness regarding HPV-related illnesses.

HPV testing and PAP test market size from the liquid-based cytology technology segment will witness over 16% CAGR from 2023-2032. Liquid-based cytology is widely employed in cervical cancer screening and includes the collection of cervical cells and their placement in liquid-based mediums for analysis. This technology is increasingly adopted in PAP tests as an alternative to traditional testing methods where cells can be directly transferred onto glass slides for examination.
 

North America HPV testing and PAP test market is expected to surpass USD 3.5 billion by 2032 due to the surging healthcare expenditure in the region. The increasing awareness related to cervical cancer has made way for a large number of supportive government initiatives. The thriving need for early disease diagnosis and the subsequently rising implementation of HPV testing as well as PAP test will influence the regional industry growth.